Side-by-side comparisons of Stock Rover and the research platforms investors most often weigh it against. Every page covers current pricing, a feature-by-feature table, and the cases where the other tool is the better choice.
Facts and pricing on all pages verified August 23, 2026.
Koyfin is a polished market-data terminal: global macro coverage, elegant charts, earnings transcripts, with a capable free tier. Stock Rover goes deeper on fundamentals, screening, and dividend history, and includes brokerage-synced portfolio reporting that Koyfin reserves for its $79/mo tier. Fund research is the sharpest split: reports on 7,400 ETFs and 20,000 funds at $79/mo billed annually, versus Koyfin’s $209/mo Advisor plans.
Finviz owns the instant market overview: the fastest heat maps on the web and a free screener everyone knows. On annual billing the paid tiers land close together ($348 vs $299.50 a year), so the choice comes down to substance: 800+ screening metrics, 20-year fundamental history, and real portfolio tools against speed, breadth, and reach.
Seeking Alpha is analysis you read: thousands of contributor articles and quant ratings at $299/yr for Premium. Stock Rover is the numbers you verify it with: screening, 20-year fundamentals, and your own portfolio’s performance. Different jobs, and the page closes with the case for pairing them.
TIKR serves deep financials on 100,000+ global tickers with earnings transcripts, starting at $24.95/mo. Stock Rover matches the history depth on US equities and adds the layer TIKR doesn’t have: brokerage sync, portfolio performance reporting, and fund research without the $119.95/mo top tier.
Simply Wall St turns analysis into pictures, and its snowflake is the friendliest on-ramp in the category ($131.40–$258/yr). Stock Rover is the step up when the caps start to bind: report views are metered by tier and screeners top out at ten, versus unlimited research and 800+ metrics.
GuruFocus goes 30 years deep with every value metric ever devised, priced for it: $424 to $1,273 a year. Stock Rover Ultimate covers the working value-investor toolkit plus the portfolio layer at $948/yr. The page maps exactly where the extra archival depth is worth the difference.
TradingView has the best charting an individual can buy, from $14.95/mo, and this page says so plainly. Stock Rover wins the other side of the job: fundamentals, screening, fund research, and portfolio reporting. Many investors sensibly run both; the page shows where the line falls.
Six platforms compared by the reason you’d switch: cost, fund-data gating, portfolio features, or ease of use. Each entry lists current pricing and where it falls short, Stock Rover included.
What individual investors actually use a terminal for, and five consumer-priced tools that cover it: deep fundamentals, screening, portfolio analytics, and fund data, all under $1,300 a year.
Five upgrades matched to the wall you hit with Finviz: research depth, technical backtesting, visual analysis, or fund coverage. Pricing and weaknesses listed for every entry.
Our own review, structured the way an outside reviewer would write it: current pricing, what V12 added, real weaknesses, and a “who shouldn’t buy” section that names the better tool for four types of investor.
What dividend screening needs that generic screeners lack: 30-year payout histories, growth streaks, safety percentiles, and a 12-month income projection on your actual holdings. Five tools compared.
Fund research is the most price-gated corner of the market. This guide compares five tools on report depth, fee analytics in dollars, and portfolio look-through, with the gates and prices named.
Every claim on these pages is testable in the 14-day trial, including the Portfolio Performance Report. No credit card required.
